Loading viewer...
investor_presentation
Format: PDF investor_presentation
Full-year 2023 financial results and performance review presented on February 22, 2024. Covers financial highlights, business strategy overview, and 2024 prospects with presentations by CEO Padma Ravichander and CFO Indiresh Vivekananda.
investor_presentation
18 Pages
investor_presentation
30 Pages
Nordic Semiconductor
Sonoma Pharmaceuticals Investor Presentation January 2023
investor_presentationinvestor_presentation
31 Pages
Sonoma Pharmaceuticals, Inc.